| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 345.691 | 428.056 | 478.906 | - | 644.630 |
| Total Income - EUR | - | - | - | - | - | 346.644 | 428.058 | 478.906 | - | 644.630 |
| Total Expenses - EUR | - | - | - | - | - | 291.768 | 374.725 | 450.989 | - | 585.023 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 54.875 | 53.333 | 27.917 | - | 59.607 |
| Net Profit/Loss - EUR | - | - | - | - | - | 51.418 | 49.566 | 23.128 | - | 50.069 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | - | 0 |
Check the financial reports for the company - Cardiogrup Research Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | - | 0 |
| Current Assets | - | - | - | - | - | 123.065 | 118.809 | 170.466 | - | 131.858 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | - | 0 |
| Receivables | - | - | - | - | - | 73.085 | 99.769 | 159.271 | - | 122.121 |
| Cash | - | - | - | - | - | 49.980 | 19.040 | 11.196 | - | 9.737 |
| Shareholders Funds | - | - | - | - | - | 51.468 | 49.614 | 23.177 | - | 50.118 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | - | 40 |
| Debts | - | - | - | - | - | 71.597 | 69.194 | 147.290 | - | 81.740 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cardiogrup Research Srl